Hospira Buys Into ChemGenex CML Drug As FDA Prepares To Take NME To Advisory Panel

A $17.8 million investment buys the big pharma a share in some ex-U.S. markets as FDA, EMEA prepare to assess the drug in chronic myeloid leukemia resistant to Gleevec.